Ascendis Pharma Says FDA Extending Review Period for NDA

Ascendis Pharma 表示 FDA 延長了保密協議的審查期

WSJ · 05/14 14:56

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.